Here we report our initial experience with 225Ac-PSMA-617 RLT in the first 17 consecutive, chemotherapy-naïve patients with advanced metastatic prostate cancer treated at Steve Biko Academic Hospital, in Pretoria, South Africa. Here, FOLH1 is linked to metastatic prostate carcinoma.